287 related articles for article (PubMed ID: 23447642)
1. miR-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat.
Merlet E; Atassi F; Motiani RK; Mougenot N; Jacquet A; Nadaud S; Capiod T; Trebak M; Lompré AM; Marchand A
Cardiovasc Res; 2013 Jun; 98(3):458-68. PubMed ID: 23447642
[TBL] [Abstract][Full Text] [Related]
2. An essential role for stromal interaction molecule 1 in neointima formation following arterial injury.
Guo RW; Wang H; Gao P; Li MQ; Zeng CY; Yu Y; Chen JF; Song MB; Shi YK; Huang L
Cardiovasc Res; 2009 Mar; 81(4):660-8. PubMed ID: 19052075
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation.
Wang YS; Wang HY; Liao YC; Tsai PC; Chen KC; Cheng HY; Lin RT; Juo SH
Cardiovasc Res; 2012 Sep; 95(4):517-26. PubMed ID: 22802111
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.
Zhou LJ; Chen XY; Liu SP; Zhang LL; Xu YN; Mu PW; Geng DF; Tan Z
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751541
[TBL] [Abstract][Full Text] [Related]
5. Small nucleolar RNA host gene 18 controls vascular smooth muscle cell contractile phenotype and neointimal hyperplasia.
Niu K; Zhang C; Yang M; Maguire EM; Shi Z; Sun S; Wu J; Liu C; An W; Wang X; Gao S; Ge S; Xiao Q
Cardiovasc Res; 2024 May; 120(7):796-810. PubMed ID: 38498586
[TBL] [Abstract][Full Text] [Related]
6. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
[TBL] [Abstract][Full Text] [Related]
7. Novel Pathological Role of hnRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) in Vascular Smooth Muscle Cell Function and Neointima Hyperplasia.
Zhang L; Chen Q; An W; Yang F; Maguire EM; Chen D; Zhang C; Wen G; Yang M; Dai B; Luong LA; Zhu J; Xu Q; Xiao Q
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2182-2194. PubMed ID: 28912364
[TBL] [Abstract][Full Text] [Related]
8. Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β.
Talasila A; Yu H; Ackers-Johnson M; Bot M; van Berkel T; Bennett MR; Bot I; Sinha S
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2355-65. PubMed ID: 23825366
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane protein 66 attenuates neointimal hyperplasia after carotid artery injury by SOCE inactivation.
Yang J; Li S; Wang Q; Yang D
Mol Med Rep; 2019 Aug; 20(2):1436-1442. PubMed ID: 31173198
[TBL] [Abstract][Full Text] [Related]
11. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.
Yang J; Fan Z; Yang J; Ding J; Yang C; Chen L
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231895
[TBL] [Abstract][Full Text] [Related]
13. Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation.
Zhang C; Chen D; Maguire EM; He S; Chen J; An W; Yang M; Afzal TA; Luong LA; Zhang L; Lei H; Wu Q; Xiao Q
Cardiovasc Res; 2018 Mar; 114(3):443-455. PubMed ID: 29206900
[TBL] [Abstract][Full Text] [Related]
14. miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration.
Chen Q; Yang F; Guo M; Wen G; Zhang C; Luong le A; Zhu J; Xiao Q; Zhang L
J Mol Cell Cardiol; 2015 Dec; 89(Pt A):75-86. PubMed ID: 26493107
[TBL] [Abstract][Full Text] [Related]
15. Flank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application.
Liu X; Cheng Y; Yang J; Qin S; Chen X; Tang X; Zhou X; Krall TJ; Zhang C
J Am Heart Assoc; 2013 Oct; 2(6):e000407. PubMed ID: 24166492
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-132 targeting PTEN contributes to cilostazol-promoted vascular smooth muscle cell differentiation.
Chen WJ; Chen YH; Hsu YJ; Lin KH; Yeh YH
Atherosclerosis; 2018 Jul; 274():1-7. PubMed ID: 29738818
[TBL] [Abstract][Full Text] [Related]
17. The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.
Tzeng BH; Chen YH; Huang CH; Lin SS; Lee KR; Chen CC
Cardiovasc Res; 2012 Dec; 96(3):533-42. PubMed ID: 22886848
[TBL] [Abstract][Full Text] [Related]
18. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.
Choe N; Kwon JS; Kim JR; Eom GH; Kim Y; Nam KI; Ahn Y; Kee HJ; Kook H
Atherosclerosis; 2013 Aug; 229(2):348-55. PubMed ID: 23880186
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats.
Lim S; Lee GY; Park HS; Lee DH; Tae Jung O; Kyoung Min K; Kim YB; Jun HS; Hak Chul J; Park KS
Cardiovasc Res; 2017 Feb; 113(2):183-194. PubMed ID: 27702762
[TBL] [Abstract][Full Text] [Related]
20. miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.
Yang F; Chen Q; He S; Yang M; Maguire EM; An W; Afzal TA; Luong LA; Zhang L; Xiao Q
Circulation; 2018 Apr; 137(17):1824-1841. PubMed ID: 29246895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
